San DiegoBiotechnologyHealth CareMedicalTherapeuticsresearch
Description
Aptose Biosciences Inc. announced a debt conversion agreement with Hanmi, as part of their corporate update. The agreement showcases the company's efforts to manage its financial position and pave the way for further developments in their clinical-stage precision oncology programs, particularly the tuspetinib-based triple drug frontline therapy for newly diagnosed acute myeloid leukemia (AML).
Company Information
Company
Aptose Biosciences
Location
12770 High Bluff Dr
San Diego, California, United States
About
Aptose Biosciences is a science-driven clinical-stage biotechnology company developing first-in-class targeted agents to address unmet clinical need in multiple hematologic malignancies.
San DiegoBiotechnologyHealth CareMedicalTherapeuticsresearch